U.S. flag

An official website of the United States government

NM_004304.5(ALK):c.3541C>T (p.Arg1181Cys) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 16, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001020559.4

Allele description [Variation Report for NM_004304.5(ALK):c.3541C>T (p.Arg1181Cys)]

NM_004304.5(ALK):c.3541C>T (p.Arg1181Cys)

Gene:
ALK:ALK receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p23.2
Genomic location:
Preferred name:
NM_004304.5(ALK):c.3541C>T (p.Arg1181Cys)
HGVS:
  • NC_000002.12:g.29220810G>A
  • NG_009445.1:g.705757C>T
  • NM_001353765.2:c.337C>T
  • NM_004304.5:c.3541C>TMANE SELECT
  • NP_001340694.1:p.Arg113Cys
  • NP_004295.2:p.Arg1181Cys
  • LRG_488:g.705757C>T
  • NC_000002.11:g.29443676G>A
  • NM_004304.4:c.3541C>T
Protein change:
R113C
Links:
dbSNP: rs56315533
NCBI 1000 Genomes Browser:
rs56315533
Molecular consequence:
  • NM_001353765.2:c.337C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004304.5:c.3541C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001182055Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Aug 16, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies.

Hooper JE, Cantor EL, Ehlen MS, Banerjee A, Malempati S, Stenzel P, Woltjer RL, Gandour-Edwards R, Goodwin NC, Yang Y, Kaur P, Bult CJ, Airhart SD, Keller C.

Sarcoma. 2015;2015:826124. doi: 10.1155/2015/826124. Epub 2015 Nov 30.

PubMed [citation]
PMID:
26696773
PMCID:
PMC4677247

Details of each submission

From Ambry Genetics, SCV001182055.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.R1181C variant (also known as c.3541C>T), located in coding exon 23 of the ALK gene, results from a C to T substitution at nucleotide position 3541. The arginine at codon 1181 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in an individual diagnosed with an embryonal rhabdomyosarcoma (Hooper JE et al. Sarcoma, 2015 Nov;2015:826124). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024